Skip to content

The latest news from the UW

Study shows new medication effectively treats underlying cause of cystic fibrosis

A final stage clinical trial of ivacaftor (VX-770) shows significantly improved lung function in subset of cystic fibrosis patients, as reported Nov. 2 in the New England Journal of Medicine. Pediatrician Dr. Bonnie W. Ramsey of Seattle Children’s Research Institute and the UW led the study.

Stories of Cambodian returnees form basis of play by drama school prof

A friends insistence that he take a trip to an unlikely destination led Mark Jenkins to write a play. The friend was artist Don Fels. The destination was Phnom Penh, Cambodia, where Jenkins met the subjects of his play — Cambodian youth who grew up in the United States but were deported back to Cambodia after serving time in American prisons.